{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:55:01Z","timestamp":1792796101617,"version":"4.5.0"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.biomaterials.2025.123735","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:36:22Z","timestamp":1758573382000},"page":"123735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Lymph node targeting nanomedicines for tumor immunotherapy"],"prefix":"10.1016","volume":"327","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-827X","authenticated-orcid":false,"given":"Xiaotong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng","family":"Junyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangqing","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0666-7634","authenticated-orcid":false,"given":"Shiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2025.123735_bib1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212476","article-title":"Cancer immunotherapies: advances and bottlenecks","volume":"14","author":"Rui","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12951-023-01977-1","article-title":"Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12964-022-00854-y","article-title":"Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons","volume":"20","author":"Naimi","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.biomaterials.2025.123735_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","article-title":"CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances","volume":"22","author":"Maalej","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123735_bib6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jconrel.2022.10.004","article-title":"Nanomedicine for advanced cancer immunotherapy","volume":"351","author":"Diep","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.tins.2022.06.006","article-title":"Control of lymph node activity by direct local innervation","volume":"45","author":"De Virgiliis","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biomaterials.2025.123735_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101534","article-title":"Innovations in lymph node targeting nanocarriers","volume":"56","author":"Kim","year":"2021","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib10","article-title":"Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering","volume":"26","author":"Wang","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2025.123735_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2006.10.005","article-title":"Targeting dendritic cells with biomaterials: developing the next generation of vaccines","volume":"27","author":"Reddy","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib12","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/CJI.0b013e3181f1d614","article-title":"Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients","volume":"33","author":"Speiser","year":"2010","journal-title":"J. Immunother."},{"key":"10.1016\/j.biomaterials.2025.123735_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2022.09.015","article-title":"Lymph node-targeting nanovaccines for cancer immunotherapy","volume":"351","author":"Wang","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib14","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/pharmaceutics14071372","article-title":"Nanomaterial-based drug delivery system targeting lymph nodes","volume":"14","author":"Cheng","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123735_bib15","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1039\/D4CS00421C","article-title":"Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond","volume":"53","author":"Hsu","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2025.123735_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40820-023-01125-2","article-title":"Application of nano-delivery systems in lymph nodes for tumor immunotherapy","volume":"15","author":"Xia","year":"2023","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.biomaterials.2025.123735_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","article-title":"Pre-metastatic niche: formation, characteristics and therapeutic implication","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biomaterials.2025.123735_bib18","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/s41467-023-38014-6","article-title":"Temperature sensitive liposome based cancer nanomedicine enables tumour lymph node immune microenvironment remodelling","volume":"14","author":"Fu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123735_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115304","article-title":"Interactions between nanoparticles and lymphatic systems: mechanisms and applications in drug delivery","volume":"209","author":"Tang","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123735_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113914","article-title":"Vaccine delivery systems toward lymph nodes","volume":"179","author":"Ding","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123735_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102640","article-title":"Nanoparticles: from synthesis to applications and beyond","volume":"303","author":"Selmani","year":"2022","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.biomaterials.2025.123735_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/pharmaceutics15020565","article-title":"Nanoparticles for lymph node-directed delivery","volume":"15","author":"Lee","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123735_bib23","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib24","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Locoregional immune checkpoint blockade and remodeling of lymph nodes by engineered dendritic cell-derived exosomes for suppressing tumor progression and metastasis","volume":"3","author":"Wang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.biomaterials.2025.123735_bib25","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.3c11464","article-title":"Dual-Responsive Nanomedicine activates programmed antitumor immunity through targeting lymphatic system","volume":"18","author":"Xiao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101621","article-title":"Nano-drug delivery systems for T cell-based immunotherapy","volume":"46","author":"Li","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2025.123735_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001962","article-title":"T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment","volume":"9","author":"Koster","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123735_bib28","article-title":"Lymph node-targeted delivery of Lonicera japonica Thunb. polysaccharides for enhancing antitumor immunotherapy","volume":"31","author":"Zhang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2025.123735_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12951-023-02022-x","article-title":"Advances in nanomedicines for lymphatic imaging and therapy","volume":"21","author":"He","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115731","article-title":"Lymph node metastasis and tumor-educated immune tolerance: potential therapeutic targets against distant metastasis","volume":"215","author":"Peng","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg2752","article-title":"CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses","volume":"379","author":"He","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2025.123735_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12016-022-08936-y","article-title":"Germinal center-related G protein-coupled receptors in antibody-mediated autoimmune skin diseases: from basic research to clinical trials","volume":"63","author":"Cao","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41392-023-01356-0","article-title":"Tumor-draining lymph node-derived tumor-specific memory CD8+ T cells: a key player in PD-1\/PD-L1 immunotherapy","volume":"8","author":"Yin","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biomaterials.2025.123735_bib34","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.7150\/ijbs.72534","article-title":"Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biomaterials.2025.123735_bib35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3892\/ijo.2024.5684","article-title":"Drug resistance and tumor immune microenvironment: an overview of current understandings","volume":"65","author":"Liu","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","article-title":"Decoding the spatiotemporal heterogeneity of tumor-associated macrophages","volume":"23","author":"Chu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123735_bib37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-024-01527-8","article-title":"Metabolic reprogramming in the tumor microenvironment of liver cancer","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2025.123735_bib39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-022-00454-5","article-title":"Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer","volume":"22","author":"Labrie","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123735_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216894","article-title":"Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies","volume":"591","author":"El-Tanani","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2025.123735_bib41","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1021\/acsnano.4c02425","article-title":"In situ sprayed exosome-cross-linked gel as artificial lymph nodes for postoperative glioblastoma immunotherapy","volume":"18","author":"Bao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib42","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Locoregional immune checkpoint blockade and remodeling of lymph nodes by engineered dendritic cell-derived exosomes for suppressing tumor progression and metastasis","volume":"3","author":"Wang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.biomaterials.2025.123735_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113917","article-title":"The ending is not the end: lymph node metastasis in oral squamous cell carcinoma","volume":"146","author":"Wei","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1449291","article-title":"Lymphatic system regulation of anti-cancer immunity and metastasis","volume":"15","author":"Lei","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104745","article-title":"The role and clinical significance of tumor-draining lymph nodes in tumor progression and immunotherapy","volume":"212","author":"Xu","year":"2025","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib46","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.3390\/ijms22179401","article-title":"Immune checkpoint therapy: tumor draining lymph nodes in the spotlights","volume":"22","author":"Fransen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2025.123735_bib47","doi-asserted-by":"crossref","first-page":"24985","DOI":"10.1021\/acsnano.5c04279","article-title":"Protein-confined rotor strategy for quantum yield enhancement in supramolecular photosensitizers toward sentinel lymph node-targeted photodynamic immunoactivation","volume":"19","author":"Qin","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib48","article-title":"Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy","volume":"16","author":"Wei","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122910","article-title":"A size-switchable nanocluster remodels the immunosuppressive microenvironment of tumor and tumor-draining lymph nodes for improved cancer immunotherapy","volume":"315","author":"Tong","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123735_bib50","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1007\/s13346-021-01015-3","article-title":"Quantitation of lymphatic transport mechanism and barrier influences on lymph node-resident leukocyte access to lymph-borne macromolecules and drug delivery systems","volume":"11","author":"Archer","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.biomaterials.2025.123735_bib51","doi-asserted-by":"crossref","DOI":"10.1042\/EBC20253008","article-title":"Emerging strategies in lymph node-targeted nano-delivery systems for tumor immunotherapy","volume":"69","author":"Zhao","year":"2025","journal-title":"Essays Biochem."},{"key":"10.1016\/j.biomaterials.2025.123735_bib52","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3390\/pharmaceutics14122752","article-title":"Locoregional lymphatic delivery systems using nanoparticles and hydrogels for anticancer immunotherapy","volume":"14","author":"Cho","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123735_bib53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2019.09.005","article-title":"Physical and chemical profiles of nanoparticles for lymphatic targeting","volume":"151\u2013152","author":"Ke","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123735_bib54","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.3390\/nano12183183","article-title":"Redox-responsive drug delivery systems: a chemical perspective","volume":"12","author":"Abed","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biomaterials.2025.123735_bib55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41565-020-0663-z","article-title":"Targeting immune cells within lymph nodes","volume":"15","author":"Porter","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg3551","article-title":"Tumor-draining lymph nodes: at the crossroads of metastasis and immunity","volume":"6","author":"du Bois","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2014.04.051","article-title":"Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers","volume":"193","author":"Ryan","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib58","article-title":"Quality of CD8+ T cell immunity evoked in lymph nodes is compartmentalized by route of antigen transport and functional in tumor context","volume":"6","author":"O'Melia","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2025.123735_bib59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41378-024-00743-z","article-title":"Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy","volume":"10","author":"Gholami","year":"2024","journal-title":"Microsyst. Nanoeng."},{"key":"10.1016\/j.biomaterials.2025.123735_bib60","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41467-021-27750-2","article-title":"Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth","volume":"13","author":"Xu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123735_bib61","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1016\/j.apsb.2024.05.010","article-title":"Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy","volume":"14","author":"Peng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123735_bib62","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1016\/j.apsb.2024.06.003","article-title":"In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123735_bib63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2022.05.055","article-title":"Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy","volume":"348","author":"Khan","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib64","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.3390\/ijms25189779","article-title":"Charge-reversal nano-drug delivery systems in the tumor microenvironment: mechanisms, challenges, and therapeutic applications","volume":"25","author":"Liang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2025.123735_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3762\/bjnano.16.10","article-title":"Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy","volume":"16","author":"Sukubo","year":"2025","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib66","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12951-023-01989-x","article-title":"Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy","volume":"21","author":"He","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.actbio.2024.12.039","article-title":"Impact of nanoparticle properties on immune cell interactions in the lymph node","volume":"193","author":"Farooq","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib68","article-title":"In situ tumor vaccine for lymph nodes delivery and cancer therapy based on small size nanoadjuvant","volume":"19","author":"Zhang","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123735_bib69","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2147\/IJN.S378217","article-title":"PDA-based drug delivery nanosystems: a potential approach for glioma treatment","volume":"17","author":"Wu","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2025.123735_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202404830","article-title":"pH-responsive \u03b2-glucans-complexed mRNA in LNPs as an oral vaccine for enhancing cancer immunotherapy","volume":"36","author":"Luo","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib71","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2022.04.013","article-title":"Targeting nucleic acid-based therapeutics to tumors: challenges and strategies for polyplexes","volume":"346","author":"Vetter","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib72","first-page":"330","article-title":"Engineering customized nanovaccines for enhanced cancer immunotherapy","volume":"36","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib73","article-title":"Endogenous\/exogenous nanovaccines synergistically enhance dendritic cell-mediated tumor immunotherapy","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib74","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1021\/acs.molpharmaceut.9b01182","article-title":"The effect of size and charge of lipid nanoparticles prepared by microfluidic mixing on their lymph node transitivity and distribution","volume":"17","author":"Nakamura","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123735_bib75","article-title":"Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy","volume":"10","author":"Liu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2025.123735_bib76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12951-021-01146-2","article-title":"Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy","volume":"19","author":"Cai","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib77","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s12272-018-1060-0","article-title":"Soft- and hard-lipid nanoparticles: a novel approach to lymphatic drug delivery","volume":"41","author":"Jeong","year":"2018","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.biomaterials.2025.123735_bib78","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12951-023-01990-4","article-title":"Multifunctional nanocarriers for targeted drug delivery and diagnostic applications of lymph nodes metastasis: a review of recent trends and future perspectives","volume":"21","author":"Lan","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib79","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2020.07.046","article-title":"Lymphatic targeting by albumin-hitchhiking: applications and optimisation","volume":"327","author":"Abdallah","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115445","article-title":"Effects of nanoparticle deformability on multiscale biotransport","volume":"213","author":"Gadalla","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123735_bib81","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2021.12.032","article-title":"Effect of micro- and nanoparticle shape on biological processes","volume":"342","author":"Hadji","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib82","article-title":"Enhancing the deformability of the adjuvant: achieving lymph node targeted delivery to elicit a long-lasting immune protection","volume":"14","author":"Wu","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib83","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1016\/j.apsb.2023.02.003","article-title":"Orchestrating antigen delivery and presentation efficiency in lymph node by nanoparticle shape for immune response","volume":"13","author":"Zhao","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123735_bib84","article-title":"Elastic nanovaccine enhances dendritic cell-mediated tumor immunotherapy","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123735_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nmat5057","article-title":"Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination","volume":"17","author":"Xia","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib86","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1007\/s13346-023-01368-x","article-title":"Combination of micelles and liposomes as a promising drug delivery system: a review","volume":"13","author":"Qian","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.biomaterials.2025.123735_bib87","doi-asserted-by":"crossref","first-page":"23797","DOI":"10.1021\/acsnano.4c09094","article-title":"Modulating elasticity of liposome for enhanced cancer immunotherapy","volume":"18","author":"Yuan","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib88","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1039\/D3NR03149G","article-title":"Biomimetic nanoplatform with selectively positioned indocyanine green for accurate sentinel lymph node imaging","volume":"15","author":"Cheng","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2025.123735_bib89","article-title":"Nanoparticles targeting lymph nodes for cancer immunotherapy: strategies and influencing factors","volume":"20","author":"Li","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123735_bib90","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1038\/s41467-025-60570-2","article-title":"Bacterial membrane nanovesicles encapsulating prodrug assemblies combine chemical and immunological therapies for chronic bacterial infection","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123735_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128513","article-title":"Protein corona, influence on drug delivery system and its improvement strategy: a review","volume":"256","author":"Guo","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib92","article-title":"Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials","volume":"3","author":"Lu","year":"2023","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.biomaterials.2025.123735_bib93","doi-asserted-by":"crossref","first-page":"18760","DOI":"10.1021\/jacs.3c07337","article-title":"Targeted and equally distributed delivery of mRNA to organs with pentaerythritol-based one-component ionizable amphiphilic janus dendrimers","volume":"145","author":"Lu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2025.123735_bib94","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41565-020-0679-4","article-title":"Programmable multistage drug delivery to lymph nodes","volume":"15","author":"Schudel","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114097","article-title":"Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers","volume":"182","author":"Haddadzadegan","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123735_bib96","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.actbio.2022.03.054","article-title":"Nanoparticles with dense poly(ethylene glycol) coatings with near neutral charge are maximally transported across lymphatics and to the lymph nodes","volume":"145","author":"McCright","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib97","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.nano.2017.08.003","article-title":"Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection site","volume":"13","author":"Ryan","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2025.123735_bib98","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jconrel.2016.07.048","article-title":"Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer","volume":"238","author":"Borrajo","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib99","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2020.06.003","article-title":"Dawn of lipid nanoparticles in lymph node targeting: potential in cancer immunotherapy","volume":"167","author":"Nakamura","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123735_bib100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2022.03.006","article-title":"Self-degradable poly(\u03b2-amino ester)s promote endosomal escape of antigen and agonist","volume":"345","author":"Liu","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib101","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-023-01723-x","article-title":"Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biomaterials.2025.123735_bib102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-bioeng-092222-034906","article-title":"Nanotechnologies for physiology-informed drug delivery to the lymphatic system","volume":"25","author":"Maisel","year":"2023","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2025.123735_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101045","article-title":"Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery","volume":"36","author":"Jiang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2025.123735_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304664","article-title":"Lymph node targeting mediated by albumin hitchhiking of synthetic Tn glycolipid leads to robust in vivo antibody production","volume":"13","author":"Thekke Veettil","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib105","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acscentsci.3c01310","article-title":"Mannosylated STING agonist drugamers for dendritic cell-mediated cancer immunotherapy","volume":"10","author":"Nguyen","year":"2024","journal-title":"ACS Central Sci"},{"key":"10.1016\/j.biomaterials.2025.123735_bib106","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jconrel.2024.04.022","article-title":"Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies - challenges and opportunities","volume":"370","author":"Simonsen","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib107","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.apsb.2022.08.020","article-title":"Cellular nanovesicles for therapeutic immunomodulation: a perspective on engineering strategies and new advances","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123735_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202209","article-title":"Boosting B cell and macrophage-mediated humoral immunity with fusion nanovesicles for triple-negative breast cancer combined therapy","volume":"12","author":"Yu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib109","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1021\/acs.bioconjchem.4c00464","article-title":"Identification of a novel vascular endothelial growth factor receptor-3-targeting peptide for molecular imaging of metastatic lymph nodes","volume":"35","author":"Yuan","year":"2024","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biomaterials.2025.123735_bib110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12951-023-01883-6","article-title":"A TMVP1-modified near-infrared nanoprobe: molecular imaging for tumor metastasis in sentinel lymph node and targeted enhanced photothermal therapy","volume":"21","author":"Wang","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib111","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1021\/acsnano.3c09201","article-title":"MRI detection of lymph node metastasis through molecular targeting of C-C chemokine receptor type 2 and monocyte hitchhiking","volume":"18","author":"Trac","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib112","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/B978-0-12-823994-0.00002-5","article-title":"Navigating the nanoscale: principles of body navigation","volume":"5","author":"Abassi","year":"2025","journal-title":"Nanotechnology Tools for Infection Control"},{"key":"10.1016\/j.biomaterials.2025.123735_bib113","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acs.chemrev.1c00484","article-title":"Click and bioorthogonal chemistry: the future of active targeting of nanoparticles for nanomedicines?","volume":"122","author":"Taiariol","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2025.123735_bib114","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1039\/D1CS00451D","article-title":"Metal-free bioorthogonal click chemistry in cancer theranostics","volume":"51","author":"Wu","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2025.123735_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12077","article-title":"Bioorthogonally surface-edited extracellular vesicles based on metabolic glycoengineering for CD44-mediated targeting of inflammatory diseases","volume":"10","author":"Lim","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biomaterials.2025.123735_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.engmed.2024.100023","article-title":"Click reaction-induced in situ nanoparticle aggregation for cancer imaging and treatment","volume":"1","author":"Yin","year":"2024","journal-title":"EngMedicine"},{"key":"10.1016\/j.biomaterials.2025.123735_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202107192","article-title":"Copper-free click chemistry: applications in drug delivery, cell tracking, and tissue engineering","volume":"34","author":"Yoon","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib118","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1021\/acsanm.5c00475","article-title":"Nano-sized liposomes for click-chemistry-based selective guiding of immune cells to neuroblastoma","volume":"8","author":"Arroyo-Nogales","year":"2025","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib119","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1021\/acsnano.3c10180","article-title":"Particle-based artificial antigen-presenting cell systems for T cell activation in adoptive T cell therapy","volume":"18","author":"Hou","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib120","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/acs.nanolett.0c04783","article-title":"Engineering nanoscale artificial antigen-presenting cells by metabolic dendritic cell labeling to potentiate cancer immunotherapy","volume":"21","author":"Xiao","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2025.123735_bib121","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1016\/j.apsb.2024.05.013","article-title":"Insights into therapeutic peptides in the cancer-immunity cycle: update and challenges","volume":"14","author":"Zhang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123735_bib122","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1021\/acs.nanolett.4c02196","article-title":"Uniform polymeric nanovaccine platform for improving the availability and efficacy of neoantigen peptides","volume":"24","author":"Chen","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2025.123735_bib123","article-title":"Zwitterionic peptide pendant as a homing agent to achieve lymphatic targeting antigen-specific immunotherapy of allergenic protein","volume":"485","author":"Li","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biomaterials.2025.123735_bib124","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202006007","article-title":"Development of a cancer vaccine using in vivo click-chemistry-mediated active lymph node accumulation for improved immunotherapy","volume":"33","author":"Qin","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib125","article-title":"Dendritic cell-mimicking nanoparticles promote mRNA delivery to lymphoid organs","volume":"10","author":"Cao","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.biomaterials.2025.123735_bib126","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/s12951-024-02835-4","article-title":"Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication","volume":"22","author":"Mengyuan","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib127","article-title":"Improving tumor treatment: Cell membrane-coated nanoparticles for targeted therapies","volume":"32","author":"Grav\u00e1n","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2025.123735_bib128","article-title":"Bioinspired micro- and nanostructured systems for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.biomaterials.2025.123735_bib129","article-title":"Boosting checkpoint immunotherapy with biomimetic nanodrug delivery systems","volume":"13","author":"Chen","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib130","first-page":"347","article-title":"Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against Kit (K641E) -mutant melanoma","volume":"46","author":"Poudel","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib131","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.biomaterials.2025.123735_bib132","article-title":"Recent advances in biomimetic nanodelivery systems for cancer Immunotherapy","volume":"32","author":"Yang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2025.123735_bib133","article-title":"Artificial cells and biomimicry cells: a rising star in the fight against cancer","volume":"32","author":"Maia","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2025.123735_bib134","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/IJN.S438359","article-title":"Enhancing Dendritic Cell Activation Through Manganese-Coated Nanovaccine Targeting the cGAS-STING Pathway","volume":"19","author":"Wang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2025.123735_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122626","article-title":"Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy","volume":"309","author":"Li","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123735_bib136","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202209245","article-title":"Cu single atom nanozyme based high-efficiency mild photothermal therapy through cellular metabolic regulation","volume":"61","author":"Chang","year":"2022","journal-title":"Angew. Chem.-Int. Edit."},{"key":"10.1016\/j.biomaterials.2025.123735_bib137","article-title":"Biomimetic cascade nanozyme catalytic system for the treatment of lymph node metastasis in gastric cancer","volume":"21","author":"Luo","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123735_bib138","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-025-02284-z","article-title":"Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123735_bib139","article-title":"Leveraging senescent cancer cell membrane to potentiate cancer immunotherapy through biomimetic nanovaccine","volume":"11","author":"Yang","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.biomaterials.2025.123735_bib140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/bab.2523","article-title":"Fusion proteins development strategies and their role as cancer therapeutic agents","volume":"71","author":"Aslam","year":"2024","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.biomaterials.2025.123735_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.101026","article-title":"Molecular mechanisms of oxidative stress in asthma","volume":"85","author":"Michaeloudes","year":"2022","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.biomaterials.2025.123735_bib142","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3390\/antiox12061199","article-title":"The glutathione system: a journey from cyanobacteria to higher eukaryotes","volume":"12","author":"Cassier-Chauvat","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.biomaterials.2025.123735_bib143","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41467-023-41592-0","article-title":"pH-gated nanoparticles selectively regulate lysosomal function of tumour-associated macrophages for cancer immunotherapy","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123735_bib144","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.3390\/nano11092222","article-title":"Redox-responsive mesoporous silica nanoparticles for cancer treatment: recent updates","volume":"11","author":"Gisbert-Garzar\u00e1n","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biomaterials.2025.123735_bib145","article-title":"Vaccination of TLR7\/8 agonist-conjugated antigen nanoparticles for cancer immunotherapy","volume":"12","author":"Wang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib146","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/pharmaceutics15041159","article-title":"Redox-responsive comparison of diselenide and disulfide core-cross-linked micelles for drug delivery application","volume":"15","author":"Yadav","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123735_bib147","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202300238","article-title":"Redox-responsive polymeric nanoparticle for nucleic acid delivery and cancer therapy: progress, opportunities, and challenges","volume":"24","author":"Xu","year":"2024","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.biomaterials.2025.123735_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113707","article-title":"Insights into stimuli-responsive diselenide bonds utilized in drug delivery systems for cancer therapy","volume":"155","author":"Shi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2025.123735_bib149","article-title":"Custom-design of multi-stimuli-responsive degradable silica nanoparticles for advanced cancer-specific chemotherapy","volume":"20","author":"Zhang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123735_bib150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/acscentsci.9b01174","article-title":"Redox-responsive polycondensate neoepitope for enhanced personalized cancer vaccine","volume":"6","author":"Wei","year":"2020","journal-title":"ACS Central Sci"},{"key":"10.1016\/j.biomaterials.2025.123735_bib151","doi-asserted-by":"crossref","first-page":"15256","DOI":"10.1039\/D4NR01763C","article-title":"Carrier-free nano-prodrugs for minimally invasive cancer therapy","volume":"16","author":"Tanita","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2025.123735_bib152","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301099","article-title":"A universal cyclodextrin-based nanovaccine platform delivers epitope peptides for enhanced antitumor immunity","volume":"12","author":"Mao","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib153","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce the risks of mRNA drug and vaccine toxicity","volume":"23","author":"Bitounis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2025.123735_bib154","doi-asserted-by":"crossref","first-page":"19218","DOI":"10.1021\/jacs.4c04331","article-title":"Stimuli-responsive mRNA vaccines to induce robust CD8+ T cell response via ROS-mediated innate immunity boosting","volume":"146","author":"Dong","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2025.123735_bib155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2022.08.001","article-title":"Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches","volume":"351","author":"Ashrafizadeh","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib156","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jconrel.2024.07.001","article-title":"A bioinspired doxorubicin-carried albumin Nanocage against aggressive Cancer via systemic targeting of tumor and lymph node metastasis","volume":"372","author":"Iqbal","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib157","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/acs.biomac.0c00518","article-title":"pH-responsive biomimetic polymeric micelles as lymph node-targeting vaccines for enhanced antitumor immune responses","volume":"21","author":"Yang","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2025.123735_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114624","article-title":"Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy","volume":"192","author":"Sun","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123735_bib159","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jconrel.2024.04.005","article-title":"Self-adjuvanting polymeric nanovaccines enhance IFN production and cytotoxic T cell response","volume":"369","author":"Zhao","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122858","article-title":"Ultra-pH-sensitive nanoplatform for precise tumor therapy","volume":"314","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123735_bib161","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1038\/s41401-022-00887-6","article-title":"Pyroptosis and pyroptosis-inducing cancer drugs","volume":"43","author":"Yang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biomaterials.2025.123735_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282244","article-title":"Promoting GSDME expression through DNA demethylation to increase chemosensitivity of breast cancer MCF-7\/Taxol cells","volume":"18","author":"Gong","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2025.123735_bib163","doi-asserted-by":"crossref","first-page":"16632","DOI":"10.1021\/acsnano.4c00876","article-title":"Stepwise ultra-pH-sensitive micelles overcome a pK(a) barrier for systemic lymph node delivery","volume":"18","author":"Bennett","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib164","article-title":"Mesoporous silica nanoparticles: Synthesis and multifaceted functionalization for controlled drug delivery","volume":"81","author":"Gupta","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib165","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1021\/acsnano.0c08384","article-title":"Mesoporous silica nanoparticles as pH-responsive carrier for the immune-activating drug resiquimod enhance the local immune response in mice","volume":"15","author":"Wagner","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib166","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/biomedicines12020417","article-title":"Tumor microenvironment-responsive drug delivery based on polymeric micelles for precision cancer therapy: strategies and prospects","volume":"12","author":"Jin","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.biomaterials.2025.123735_bib167","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41467-025-56768-z","article-title":"A multistage drug delivery approach for colorectal primary tumors and lymph node metastases","volume":"16","author":"Yuan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123735_bib168","article-title":"Pyruvate kinase M2-responsive release of paclitaxel and indoleamine 2,3-dioxygenase inhibitor for immuno-chemotherapy of nonsmall cell lung cancer","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.biomaterials.2025.123735_bib169","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409914","article-title":"Transformable gel-to-nanovaccine enhances cancer immunotherapy via metronomic-like immunomodulation and collagen-mediated paracortex delivery","volume":"36","author":"Jin","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib170","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1021\/acs.nanolett.2c00185","article-title":"A pH-\/enzyme-responsive nanoparticle selectively targets endosomal Toll-like receptors to potentiate robust cancer vaccination","volume":"22","author":"Xia","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2025.123735_bib171","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1021\/jacs.0c01928","article-title":"Potent and prolonged innate immune activation by enzyme-responsive imidazoquinoline TLR7\/8 agonist prodrug vesicles","volume":"142","author":"Wang","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2025.123735_bib172","article-title":"Spatiotemporal nano-regulator unleashes anti-tumor immunity by overcoming dendritic cell tolerance and T cell exhaustion in tumor-draining lymph nodes","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib173","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/s12951-024-02930-6","article-title":"Intestinal nanoparticle delivery and cellular response: a review of the bidirectional nanoparticle-cell interplay in mucosa based on physiochemical properties","volume":"22","author":"Wang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib174","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2023.06.024","article-title":"Nanoparticle oral absorption and its clinical translational potential","volume":"360","author":"Kim","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib175","doi-asserted-by":"crossref","first-page":"13044","DOI":"10.1021\/acsnano.3c02403","article-title":"Mechanisms of nanoparticle transport across intestinal tissue: an oral delivery perspective","volume":"17","author":"Ejazi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib176","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/vaccines12040355","article-title":"Intranodal injection of immune activator demonstrates antitumor efficacy in an adjuvant approach","volume":"12","author":"Josi","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.biomaterials.2025.123735_bib177","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10705","article-title":"Intra-lymph node crosslinking of antigen-bearing polymers enhances humoral immunity and dendritic cell activation","volume":"9","author":"Euliano","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biomaterials.2025.123735_bib178","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2024.04.047","article-title":"Oral targeted drug delivery to post-gastrointestinal sites","volume":"370","author":"Han","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib179","article-title":"Lymph node targeting for immunotherapy","volume":"20","author":"Wang","year":"2023","journal-title":"Immunooncol Technol"},{"key":"10.1016\/j.biomaterials.2025.123735_bib180","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acsbiomaterials.1c01274","article-title":"Nanotechnology-based approaches to promote lymph node targeted delivery of cancer vaccines","volume":"8","author":"He","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biomaterials.2025.123735_bib181","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jconrel.2022.10.002","article-title":"Glycosylation of OVA antigen-loaded PLGA nanoparticles enhances DC-targeting for cancer vaccination","volume":"351","author":"Chou","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121489","article-title":"Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity","volume":"284","author":"Xu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123735_bib183","first-page":"924","article-title":"Biomaterials nanoplatform-based tumor vaccines for immunotherapy","volume":"51","author":"Li","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib184","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/nano11071700","article-title":"Theragnostic glycol chitosan-conjugated gold nanoparticles for photoacoustic imaging of regional lymph nodes and delivering tumor antigen to lymph nodes","volume":"11","author":"Sun","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biomaterials.2025.123735_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114801","article-title":"Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes","volume":"244","author":"Coluccia","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2025.123735_bib186","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/jfb15120372","article-title":"Improving the anti-tumor effect of indoleamine 2,3-dioxygenase inhibitor CY1-4 by CY1-4 nano-skeleton drug delivery system","volume":"15","author":"Li","year":"2024","journal-title":"J. Func. Biomater"},{"key":"10.1016\/j.biomaterials.2025.123735_bib187","doi-asserted-by":"crossref","first-page":"13268","DOI":"10.1021\/acsnano.0c05062","article-title":"Efficient lymph node-targeted delivery of personalized cancer vaccines with reactive oxygen species-inducing reduced graphene oxide nanosheets","volume":"14","author":"Xu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib188","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41591-023-02760-3","article-title":"Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial","volume":"30","author":"Pant","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2025.123735_bib189","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1002\/ijc.34453","article-title":"A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma","volume":"152","author":"Ishihara","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123735_bib190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12017-021-08669-9","article-title":"Contemporary RNA therapeutics for glioblastoma","volume":"24","author":"Melnick","year":"2022","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.biomaterials.2025.123735_bib191","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1007\/s00330-024-10838-w","article-title":"Ferumoxtran-10-enhanced MRI for pre-operative metastatic lymph node detection in pancreatic, duodenal, or periampullary adenocarcinoma","volume":"34","author":"Litjens","year":"2024","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib192","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/JS9.0000000000001873","article-title":"Effect of carbon nanoparticle suspension injection versus indocyanine green tracer in guiding lymph node dissection during radical gastrectomy (FUTURE-01): a randomized clinical trial","volume":"111","author":"Tian","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.biomaterials.2025.123735_bib193","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1435627","article-title":"Hyaluronic acid modified indocyanine green nanoparticles: a novel targeted strategy for NIR-II fluorescence lymphatic imaging","volume":"12","author":"Zhang","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.biomaterials.2025.123735_bib194","article-title":"CCR7 mediated mimetic dendritic cell vaccine homing in lymph node for head and neck squamous cell carcinoma therapy","volume":"10","author":"Xu","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.biomaterials.2025.123735_bib195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2022.11.036","article-title":"siRNA delivery to lymphatic endothelial cells via ApoE-mediated uptake by lipid nanoparticles","volume":"353","author":"Sakurai","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124074","article-title":"A novel FK506-loading mesoporous silica nanoparticle homing to lymph nodes for transplant rejection treatment","volume":"656","author":"Song","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123735_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141345","article-title":"Enhanced mucosal immune response through nanoparticle delivery system based on chitosan-catechol and a recombinant antigen targeted towards M cells","volume":"306","author":"Wan","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib198","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1021\/acs.nanolett.4c06123","article-title":"Development of a cascade-targeting oral vaccine via glycoprotein 2 on intestinal microfold cells for cancer immunotherapy","volume":"25","author":"Li","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2025.123735_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120167","article-title":"An ex vivo investigation of the intestinal uptake and translocation of nanoparticles targeted to Peyer's patches microfold cells","volume":"594","author":"Jia","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123735_bib200","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jconrel.2022.10.053","article-title":"Nanoadjuvants actively targeting lymph node conduits and blocking tumor invasion in lymphatic vessels","volume":"352","author":"Liu","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122869","article-title":"Engineering cell membrane-camouflaged COF-based nanosatellite for enhanced tumor-targeted photothermal chemoimmunotherapy","volume":"314","author":"Lin","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123735_bib202","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jconrel.2022.03.054","article-title":"Systemic nano-delivery of low-dose STING agonist targeted to CD103+ dendritic cells for cancer immunotherapy","volume":"345","author":"Doshi","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib203","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202410715","article-title":"A minimalist pathogen-like sugar nanovaccine for enhanced cancer immunotherapy","volume":"36","author":"Miao","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib204","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1021\/acsnano.4c07360","article-title":"Carbohydrate-lectin interactions reprogram dendritic cells to promote type 1 anti-tumor immunity","volume":"18","author":"Lensch","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib205","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ijbiomac.2022.10.184","article-title":"Development and characterization of DEC-205 receptor targeted Potentilla anserina L polysaccharide PLGA nanoparticles as an antigen delivery system to enhance in vitro and in vivo immune responses in mice","volume":"224","author":"Wu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib206","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008342","article-title":"Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fc\u03b3 and Fc\u03b1 receptors","volume":"12","author":"Feola","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123735_bib207","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1021\/acsnano.4c14513","article-title":"Bifunctional phage particles augment CD40 activation and enhance lymph node-targeted delivery of personalized neoantigen vaccines","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib208","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.1021\/acs.nanolett.2c03234","article-title":"Phosphatidylserine lipid nanoparticles promote systemic RNA delivery to secondary lymphoid organs","volume":"22","author":"Luozhong","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2025.123735_bib209","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202528","article-title":"Delivering mRNA to secondary lymphoid tissues by phosphatidylserine-loaded lipid nanoparticles","volume":"12","author":"Gomi","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib210","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2147\/IJN.S480553","article-title":"CD44-receptors-mediated multiprong targeting strategy against breast cancer and tumor-associated macrophages: design, optimization, characterization, and cytologic evaluation","volume":"20","author":"Hussain","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2025.123735_bib211","article-title":"Synergistic target-attacking tumor cells and M2 macrophages via a triple-responsive nanoassembly for complete metastasis blocking","volume":"14","author":"Wang","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2025.123735_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124254","article-title":"Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity","volume":"660","author":"Bouma","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123735_bib213","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12951-024-03051-w","article-title":"Ultrasound nanodroplets loaded with Siglec-G siRNA and Fe3O4 activate macrophages and enhance phagocytosis for immunotherapy of triple-negative breast cancer","volume":"22","author":"Yin","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib214","article-title":"Benefits of an immunogenic personalized neoantigen nanovaccine in patients with high-risk gastric\/gastroesophageal junction cancer","volume":"10","author":"Liu","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.biomaterials.2025.123735_bib215","first-page":"A867","article-title":"772 Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy","volume":"11","author":"Doonan","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123735_bib216","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417535","article-title":"OncoTherad\u00ae (MRB-CFI-1) nanoimmunotherapy: a promising strategy to treat bacillus calmette-gu\u00e9rin-unresponsive non-muscle-invasive bladder cancer: crosstalk among T-cell CX3CR1, immune checkpoints, and the Toll-like receptor 4 signaling pathway","volume":"24","author":"Alonso","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2025.123735_bib217","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/ajh.24093","article-title":"A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL\/GRAALL-SA2-2008 study","volume":"90","author":"Hunault-Berger","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib218","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy288.109","article-title":"A first-in-human phase I\/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma","volume":"29","author":"Jabulowsky","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123735_bib219","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1479-5876-10-156","article-title":"First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients","volume":"10","author":"Berinstein","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biomaterials.2025.123735_bib220","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ymthe.2025.01.008","article-title":"Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates","volume":"33","author":"Buckley","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2025.123735_bib221","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.2147\/IJN.S429626","article-title":"Temperature-sensitive nanocarbon hydrogel for photothermal therapy of tumors","volume":"18","author":"Tan","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2025.123735_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121790","article-title":"\"Nanodecoys\" - future of drug delivery by encapsulating nanoparticles in natural cell membranes","volume":"621","author":"Imran","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123735_bib223","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.apsb.2021.12.021","article-title":"Emerging vaccine nanotechnology: from defense against infection to sniping cancer","volume":"12","author":"Feng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123735_bib224","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jconrel.2025.01.069","article-title":"Microneedle-delivered adeno-associated virus vaccine amplified anti-viral immunity by improving antigen-presenting cells infection","volume":"379","author":"He","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123735_bib225","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/acsnano.4c09566","article-title":"Transforming medicine: cutting-edge applications of nanoscale materials in drug delivery","volume":"19","author":"Tenchov","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123735_bib226","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biomaterials.2025.123735_bib227","article-title":"Stem cell membrane-camouflaged targeted delivery system in tumor, Mater","volume":"16","author":"Zhang","year":"2022","journal-title":"Today Bio"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225006544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225006544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:54:11Z","timestamp":1780476851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225006544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":227,"alternative-id":["S0142961225006544"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123735","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymph node targeting nanomedicines for tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123735"}}